{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:02Z","timestamp":1786982762123,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40263-019-00608-4","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T05:50:07Z","timestamp":1549864207000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review"],"prefix":"10.1007","volume":"33","author":[{"given":"Wenyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguo","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-0325","authenticated-orcid":false,"given":"Yinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"issue":"9675","key":"608_CR1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","volume":"373","author":"AI Qureshi","year":"2009","unstructured":"Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632\u201344.","journal-title":"Lancet"},{"issue":"2","key":"608_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/STROKEAHA.109.552919","volume":"41","author":"T Steiner","year":"2010","unstructured":"Steiner T, Bosel J. Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke. 2010;41(2):402\u20139.","journal-title":"Stroke"},{"issue":"9457","key":"608_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","volume":"365","author":"AD Mendelow","year":"2005","unstructured":"Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365(9457):387\u201397.","journal-title":"Lancet"},{"issue":"9890","key":"608_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","volume":"382","author":"AD Mendelow","year":"2013","unstructured":"Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397\u2013408.","journal-title":"Lancet"},{"issue":"8","key":"608_CR5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamaneurol.2017.1014","volume":"74","author":"A Morotti","year":"2017","unstructured":"Morotti A, Brouwers HB, Romero JM, Jessel MJ, Vashkevich A, Schwab K, et al. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol. 2017;74(8):950\u201360.","journal-title":"JAMA Neurol"},{"issue":"25","key":"608_CR6","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","volume":"368","author":"CS Anderson","year":"2013","unstructured":"Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355\u201365.","journal-title":"N Engl J Med"},{"issue":"6","key":"608_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL. Tranexamic acid\u2014a review of its use in surgery and other indications. Drugs. 1999;57(6):1005\u201332.","journal-title":"Drugs"},{"key":"608_CR8","first-page":"CD004896","volume":"12","author":"I Roberts","year":"2012","unstructured":"Roberts I, Shakur H, Ker K, Coats T, Roberts I. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2012;12:CD004896.","journal-title":"Cochrane Database Syst Rev"},{"issue":"344","key":"608_CR9","doi-asserted-by":"publisher","first-page":"e3054","DOI":"10.1136\/bmj.e3054","volume":"17","author":"K Ker","year":"2012","unstructured":"Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;17(344):e3054.","journal-title":"BMJ"},{"issue":"4","key":"608_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJM199807233390407","volume":"339","author":"PM Mannucci","year":"1998","unstructured":"Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339(4):245\u201353.","journal-title":"N Engl J Med"},{"issue":"9734","key":"608_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"H Shakur","year":"2010","unstructured":"CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23\u201332.","journal-title":"Lancet"},{"key":"608_CR12","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1136\/bmj.d3795","volume":"343","author":"Crash-2 Collaborators IBS","year":"2011","unstructured":"Crash-2 Collaborators IBS. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ. 2011;343:3795.","journal-title":"BMJ"},{"issue":"10135","key":"608_CR13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","volume":"391","author":"N Sprigg","year":"2018","unstructured":"Sprigg N, Flaherty K, Appleton JP, Salman RA-S, Bereczki D, Beridze M, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107\u201315.","journal-title":"Lancet"},{"issue":"6118","key":"608_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","volume":"1","author":"RS Maurice-Williams","year":"1978","unstructured":"Maurice-Williams RS. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? British medical journal. 1978;1(6118):945\u20137.","journal-title":"British medical journal."},{"issue":"1","key":"608_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/WNL.54.1.77","volume":"54","author":"Y Roos","year":"2000","unstructured":"Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. Neurology. 2000;54(1):77.","journal-title":"Neurology"},{"issue":"1\u20132","key":"608_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01402177","volume":"102","author":"SA Tsementzis","year":"1990","unstructured":"Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien). 1990;102(1\u20132):1\u201310.","journal-title":"Acta Neurochir (Wien)"},{"issue":"7","key":"608_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM198408163110703","volume":"311","author":"M Vermeulen","year":"1984","unstructured":"Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311(7):432\u20137.","journal-title":"N Engl J Med"},{"issue":"13","key":"608_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-227X-13-20","volume":"22","author":"S Yutthakasemsunt","year":"2013","unstructured":"Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;22(13):20.","journal-title":"BMC Emerg Med"},{"issue":"6","key":"608_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","volume":"23","author":"N Sprigg","year":"2014","unstructured":"Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis. 2014;23(6):1312\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"608_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","volume":"10","author":"M Kaste","year":"1979","unstructured":"Kaste M, Ramsay M. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke. 1979;10(5):519\u201322.","journal-title":"Stroke"},{"issue":"1","key":"608_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"2","key":"608_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","volume":"8","author":"H Fodstad","year":"1981","unstructured":"Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery. 1981;8(2):158\u201365.","journal-title":"Neurosurgery"},{"issue":"1","key":"608_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13063-017-2341-5","volume":"18","author":"K Flaherty","year":"2017","unstructured":"Flaherty K, Bath PM, Dineen R, Law Z, Scutt P, Pocock S, et al. Statistical analysis plan for the \u2018Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage\u2019 (TICH-2) trial. Trials. 2017;18(1):607.","journal-title":"Trials"},{"issue":"13","key":"608_CR24","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta16130","volume":"16","author":"P Perel","year":"2012","unstructured":"Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury\u2014a nested randomised, placebo-controlled trial. Health Technol Assess. 2012;16(13):iii\u2013vii, 1\u201354.","journal-title":"Health Technol Assess."},{"issue":"4","key":"608_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","volume":"97","author":"J Hillman","year":"2002","unstructured":"Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97(4):771\u20138.","journal-title":"J Neurosurg"},{"key":"608_CR26","first-page":"62","volume":"22","author":"A Arumugam","year":"2015","unstructured":"Arumugam A, Rahman NAA, Theophilus SC, Shariffudin A, Abdullah JM. Tranexamic acid as antifibrinolytic agent in non traumatic intracerebral hemorrhages. Malays J Med Sci. 2015;22:62\u201371.","journal-title":"Malays J Med Sci"},{"issue":"1","key":"608_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","volume":"20","author":"A Jokar","year":"2017","unstructured":"Jokar A, Ahmadi K, Salehi T, Sharif-Alhoseini M, Rahimi-Movaghar V. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial. Chin J Traumatol. 2017;20(1):49\u201351.","journal-title":"Chin J Traumatol"},{"issue":"546","key":"608_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/pgmj.47.546.199","volume":"47","author":"JR Gibbs","year":"1971","unstructured":"Gibbs JR, Corkill AG. Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms. Postgrad Med J. 1971;47(546):199\u2013200.","journal-title":"Postgrad Med J"},{"issue":"9771","key":"608_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","volume":"377","author":"I Roberts","year":"2011","unstructured":"CRASH-2 Collaborators, Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. The Lancet. 2011;377(9771):1096\u20131101.e2.","journal-title":"The Lancet."},{"issue":"10116","key":"608_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","volume":"391","author":"A Gayet-Ageron","year":"2018","unstructured":"Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron F-X, Roberts I, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40\u2008138 bleeding patients. Lancet. 2018;391(10116):125\u201332.","journal-title":"Lancet"},{"key":"608_CR31","first-page":"CD001245","volume":"8","author":"MI Baharoglu","year":"2013","unstructured":"Baharoglu MI, Germans MR, Rinkel GJ, Algra A, Vermeulen M, van Gijn J, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2013;8:CD001245.","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"608_CR32","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","volume":"358","author":"SA Mayer","year":"2008","unstructured":"Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127\u201337.","journal-title":"N Engl J Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-019-00608-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:19:14Z","timestamp":1581362354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-019-00608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1007\/s40263-019-00608-4","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"11 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Wenyu Hu, Yanguo Xin, Xin Chen, Zhuyin Song, Zhiyi He, and Yinan Zhao have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}